Bruna Bologna Catinelli

Dr. Bruna Bologna Catinelli

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2020 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
TGThe Diamater Study Group
The Diamater Study Group
MRMarilza Vieira Cunha Rudge
Marilza Vieira Cunha Rudge
FSFátima Souza
Fátima Souza
JAJoelcio Francisco Abbade
Joelcio Francisco Abbade
Raghavendra LS HLRaghavendra LS HL
Raghavendra LS HL
MKM. R. Kron
M. R. Kron
Background: Pelvic floor muscles (PFM) and rectus abdominis muscles (RAM) of pregnant diabetic rats exhibit atrophy, co-localization of fast and slow fibers and an increased collagen type I/III ratio. However, the role of similar PFM or RAM hyperglycemic-related myopathy in women with gestational diabetes mellitus (GDM) remains poorly investigated. This study aims to assess the frequency of pelvic floor muscle disorders and pregnancy-specific urinary incontinence (PS-UI) 12 months after the Cesarean (C) section in women with GDM. Specifically, differences in PFM/RAM hyperglycemic myopathy will be evaluated. Methods: The Diamater is an ongoing cohort study of four groups of 59 pregnant women each from the Perinatal Diabetes Research Centre (PDRC), Botucatu Medical School (FMB)-UNESP (São Paulo State University), Brazil. Diagnosis of GDM and PS-UI will be made at 24–26 weeks, with a follow-up at 34–38 weeks of gestation. Inclusion in the study will occur at the time of C-section, and patients will be followed at 24–48 h, 6 weeks and 6 and 12 months postpartum. Study groups will be classified as (1) GDM plus PS-UI; (2) GDM without PS-UI; (3) Non-GDM plus PS-UI; and (4) Non-GDM without PS-UI. We will analyze relationships between GDM, PS-UI and hyperglycemic myopathy at 12 months after C-section. The mediator variables to be evaluated include digital palpation, vaginal squeeze pressure, 3D pelvic floor ultrasound, and 3D RAM ultrasound. RAM samples obtained during C-section will be analyzed for ex-vivo contractility, morphological, molecular and OMICS profiles to further characterize the hyperglycemic myopathy. Additional variables to be evaluated include maternal age, socioeconomic status, educational level, ethnicity, body mass index, weight gain during pregnancy, quality of glycemic control and insulin therapy. Discussion: To our knowledge, this will be the first study to provide data on the prevalence of PS-UI and RAM and PFM physical and biomolecular muscle profiles after C-section in mothers with GDM. The longitudinal design allows for the assessment of cause-effect relationships between GDM, PS-UI, and PFMs and RAMs myopathy. The findings may reveal previously undetermined consequences of GDM.

28 August 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
HBHenrique Caetano Mingoranci Bassin
Henrique Caetano Mingoranci Bassin
ABAngélica Mércia Pascon Barbosa
Angélica Mércia Pascon Barbosa
CPCaroline Baldini Prudencio
Caroline Baldini Prudencio
Luis SobreviaLuis Sobrevia
Luis Sobrevia
VBVitoria Pascon Barbosa
Vitoria Pascon Barbosa
DGDiamater Study Group
Diamater Study Group
Introduction and Hypothesis: Pregnancy-specific urinary incontinence (PS-UI) is defined as any onset of new urinary leakage during pregnancy. The study aims to analyze the prevalence and risk factors of PS-UI. We hypothesized that demographic and clinical factors, including Gestational Diabetes, may contribute to the development of PS-UI. Methods: We recruited pregnant women from the Diamater cohort study. We evaluated the maternal characteristics, demographics, anthropometrics, hyperglycemic status, and the PS-UI occurrence. A logistic regression model was performed considering the clinical variables to determine the predictive factors for PS-UI occurrence. Results: PS-UI was prevalent in 62.1% of women. Among these, 58.85% began leaking urine between 24–28 gestational weeks. Additionally, 51% developed PS-UI at the end of pregnancy. The pregestational BMI is a risk factor for PS-UI, and physical activity is a protective factor that halves the risk of PS-UI developing. Conclusions: Weight management and encouragement to engage in physical activity during pregnancy should be emphasized in prenatal care to reduce the risk of PS-UI. Further studies are suggested to evaluate the impact of the association due to UI later in life.

17 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HBHenrique Caetano Mingoranci Bassin
Henrique Caetano Mingoranci Bassin
ABAngélica Mércia Pascon Barbosa
Angélica Mércia Pascon Barbosa
CPCaroline Baldini Prudencio
Caroline Baldini Prudencio
Luis SobreviaLuis Sobrevia
Luis Sobrevia
VBVitoria Pascon Barbosa
Vitoria Pascon Barbosa
MRMarilza Vieira Cunha Rudge
Marilza Vieira Cunha Rudge
Introduction and Hypothesis: Pregnancy-specific urinary incontinence (PS-UI) is defined as any onset of new urinary leakage during pregnancy. The study aims to analyze the prevalence and risk factors of PS-UI. We hypothesized that demographic and clinical factors, including Gestational Diabetes, may contribute to the development of PS-UI. Methods: We recruited pregnant women from the Diamater cohort study. We evaluated the maternal characteristics, demographics, anthropometrics, hyperglycemic status, and the PS-UI occurrence. A logistic regression model was performed considering the clinical variables to determine the predictive factors for PS-UI occurrence. Results: PS-UI was prevalent in 62.1% of women, 58.85% began leaking urine between 24 and 28 gestational weeks, and 51% developed PS-UI at the end of pregnancy. The pregestational BMI is a risk factor for PS-UI, and physical activity is a protective factor that halves the risk of PS-UI developing. Conclusions: The weight management and encouragement to engage in physical activity during pregnancy should be emphasized in prenatal care to reduce the risk of PS-UI. Further studies are suggested to evaluate the impact of the association due to UI later in life.

25 November 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
BCBruna Bologna Catinelli
Bruna Bologna Catinelli
ABAngélica Mércia Pascon Barbosa
Angélica Mércia Pascon Barbosa
ACAline Medolago Carr
Aline Medolago Carr
Rafael Guilen de OliveiraRafael Guilen de Oliveira
Rafael Guilen de Oliveira
FAFernanda Cristina Bergamo Alves
Fernanda Cristina Bergamo Alves
MRMarilza Vieira Cunha Rudge
Marilza Vieira Cunha Rudge